Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Sees Large Drop in Short Interest

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) saw a large decrease in short interest during the month of October. As of October 15th, there was short interest totalling 1,500 shares, a decrease of 42.3% from the September 30th total of 2,600 shares. Based on an average daily volume of 16,300 shares, the days-to-cover ratio is currently 0.1 days.

Reviva Pharmaceuticals Stock Down 9.2 %

Shares of RVPHW opened at $0.11 on Friday. The firm’s fifty day simple moving average is $0.13 and its two-hundred day simple moving average is $0.24. Reviva Pharmaceuticals has a 12 month low of $0.07 and a 12 month high of $1.72.

Reviva Pharmaceuticals Company Profile

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.